rs542192037
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001008216.2(GALE):c.647C>T(p.Ala216Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000688 in 1,613,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A216A) has been classified as Likely benign.
Frequency
Consequence
NM_001008216.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALE | NM_001008216.2 | c.647C>T | p.Ala216Val | missense_variant | 8/12 | ENST00000617979.5 | NP_001008217.1 | |
GALE | NM_000403.4 | c.647C>T | p.Ala216Val | missense_variant | 8/12 | NP_000394.2 | ||
GALE | NM_001127621.2 | c.647C>T | p.Ala216Val | missense_variant | 7/11 | NP_001121093.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALE | ENST00000617979.5 | c.647C>T | p.Ala216Val | missense_variant | 8/12 | 1 | NM_001008216.2 | ENSP00000483375.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248540Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134424
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1460798Hom.: 0 Cov.: 35 AF XY: 0.0000661 AC XY: 48AN XY: 726590
GnomAD4 genome AF: 0.000112 AC: 17AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74446
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 01, 2017 | - - |
UDPglucose-4-epimerase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The GALE c.647C>T (p.Ala216Val) missense variant has been reported in one study in which it is found in a compound heterozygous state in one individual with peripheral GALE deficiency (Li et al. 2014). Control data are unavailable for this variant, which is reported at a frequency of 0.00033 in the African population of the Exome Aggregation Consortium. GALE activity in patient erythrocytes was reduced to 0.5% of the mean GALE activity for controls. The evidence for this variant is limited. The p.Ala216Val variant is therefore classified as a variant of unknown significance, but suspicious for pathogenicity for epimerase deficiency galactosemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at